中文名稱:利拉利汀

中文同義詞:LINAGLIPTIN利拉利汀(BI-1356);利格利汀;歐唐寧;利納利汀;利拉利汀原料藥;利格列汀

英文名稱:Linagliptin

英文同義詞:linagliptin;8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;(R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione;1H-Purine-2,6-dione,8-((3R)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-;Bi1356;Ondero;

CAS號(hào):668270-12-0

分子式:C25H28N8O2

分子量:472.54

純度： 99%

質(zhì)量標(biāo)準(zhǔn)：企業(yè)標(biāo)準(zhǔn)

備注：現(xiàn)貨供應(yīng)

相關(guān)類別:醫(yī)藥原料，精細(xì)化工品;對(duì)照品-雜質(zhì)對(duì)照品;糖尿病;其他雜環(huán);原料藥;醫(yī)藥原料;小分子抑制劑;醫(yī)藥原料藥;蛋白酶;醫(yī)藥抑制劑;醫(yī)用原料;對(duì)照品-中藥對(duì)照品;藥物雜質(zhì)及中間體;